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ABSTRACT 
The 7q11.23 microduplication syndrome, caused by the reciprocal duplication of the Williams-
Beuren syndrome (WBS) deletion region, is a genomic disorder with an emerging clinical 
phenotype. Dysmorphic features, congenital anomalies, hypotonia, developmental delay 
highlighted by variable speech delay, and autistic features are characteristic findings.  Congenital 
heart defects, most commonly patent ductus arteriosus, have been reported in a minority of cases.  
Included in the duplicated region is elastin (ELN), implicated as the cause of supravalvar aortic 
stenosis in WBS.  Here we present a series of eight pediatric patients and one adult with 7q11.23 
microduplication syndrome, all of whom have aortic dilation, the opposite vascular phenotype of 
the typical supravalvar aortic stenosis found in WBS.  The ascending aorta was most commonly 
involved, while dilation was less frequently identified at the aortic root and sinotubular junction.    
The findings in these patients support a recommendation for cardiovascular surveillance in 
patients with 7q11.23 microduplication syndrome.   
Key words: 7q11.23 microduplication, Williams-Beuren, thoracic aortic aneurysm, elastin, 
pediatrics   
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INTRODUCTION 
The 7q11.23 microduplication syndrome is caused by the reciprocal duplication of the 
Williams-Beuren syndrome (WBS) deletion region.  Deletions and duplications in this region 
arise due to non-allelic homologous recombination between low copy number repeat sequences.  
Williams syndrome has a prevalence of approximately 1/7,500-1/10,000 births [Stromme et al., 
2002], whereas the prevalence of the 7q11.23 microduplication has been estimated to be 
1/13,000-1/20,000 [Van der Aa et al., 2009].   
The 7q11.23 microduplication syndrome was first reported in 2005 [Somerville et al., 
2005].    Since that time, several case reports have been published including two recent larger 
case series [Dixit et al., 2013; Van der Aa et al., 2009].  The clinical phenotype continues to 
emerge and includes dysmorphic features, developmental delay with variable speech delay (most 
commonly expressive language delay), autistic features, hypotonia and various congenital 
anomalies including cryptorchidism.  The aforementioned case series describe dysmorphic 
features that may outline a characteristic and recognizable facial phenotype including straight 
and neatly placed eyebrows, broad forehead, high broad nose, short philtrum, thin upper lip, and 
various ear abnormalities. Abnormal brain MRI findings as well as seizures have been reported.  
Additionally, neurobehavioral concerns including self-mutilating behavior, agitation, and 
aggressive behavior have been described in adults [Van der Aa et al., 2009].  The 
microduplication has also been identified in a large schizophrenia cohort.  These individuals 
were noted to have a history of social anxiety and language delay predating their schizophrenia 
diagnosis [Mulle et al., 2013].  Congenital heart disease has been reported previously.  In one 
series of 14 individuals, three were found to have a patent ductus arteriosus, and one further 
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patient had an atrial septal defect [Van der Aa et al., 2009].  One patient has been reported to 
have supravalvar aortic stenosis (SVAS) with post-stenotic dilation [Orellana et al., 2008].   
Included in the region of the duplication is elastin (ELN).  Elastin (derived from 
tropoelastin) is an essential component of elastic fibers, which are highly organized extracellular 
matrix proteins present in tissues that require elasticity, or the ability to deform and recoil, such 
as arteries [Baldwin et al., 2013; Rosenbloom et al., 1993].  Decreased dosage of ELN is 
implicated as the cause of SVAS in WBS, and both ELN deletions and mutations have been 
identified in individuals without WBS who have SVAS [Ewart et al., 1994; Li et al., 1997; 
Metcalfe et al., 2000].  Furthermore, ELN mutations have also been identified in patients with 
autosomal dominant cutis laxa and thoracic aortic aneurysm and dissection [Szabo et al., 2006].  
These findings demonstrate the deleterious effects of decreased ELN dosage or abnormal gene 
function on the aorta. The effect of increased ELN dosage on the aorta has not been reported.   
METHODS 
Seven patients in three families were identified through standard clinical practice at two 
institutions.  Two additional patients were identified through Medical Genetics Laboratory 
(MGL) at Baylor College of Medicine.  Patients included in this report had echocardiographic 
data available.   
A microduplication of 1.42 Mb and 1.45 Mb of 7q11.23 was identified by single 
nucleotide polymorphism (SNP) Microarray (Illumina HD Human610-quad BeadChip platform) 
in the probands in Families A and B, respectively (Patient’s 1 and 3).  In Family A, the 
duplication was identified in the proband’s maternal half-sibling (Patient 2) through fluorescence 
in situ hybridization (FISH) using the Vysis Williams Probe.  The mother in Family A has been 
confirmed to have the microduplication but has not been evaluated clinically, and thus is not 
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included in this series.  In Family B, the duplication was also identified through FISH using the 
Vysis Williams Probe in a full sibling and a maternal half-sibling (Patients 4 and 5).  The mother 
in Family B (Patient 6) is a presumed carrier of the microduplication due to the presence of 
consistent features including dysmorphic features and learning disability, and the transmission of 
the duplication to children with different fathers.  However confirmatory genetic testing has not 
been completed so the possibility of germline mosaicism cannot be formally excluded.   
Patient 7 with ∼1.1 Mb duplication and patient 8 with ∼1.5 Mb de novo duplication were 
screened using custom-designed exon-targeted array-CGH oligonucleotide microarrays (patient 7 
V7.4 OLIGO, 105K; patient 8 V8.1 OLIGO, 180K) designed by MGL at BCM 
(http://www.bcm.edu/geneticlabs) and manufactured by Agilent Technology (Santa Clara, CA), 
as previously described [Boone et al., 2010].  The parents of Patient 7 have not had parental 
testing for the duplication, and Patient 8 has a de novo duplication. 
The 7q11.23 microduplication in patient 9 was also identified using a SNP microarray 
platform (Affymetrix CytoScan HD) and confirmed by both metaphase and interphase 
fluorescence in situ hybridization (FISH) using Empire Genomics’ RP11-19F19 probe.  . The 
duplication involved 1,564 markers and approximately 1.4 Mb of genetic material.  Although no 
paternal sample has been received for follow-up testing, maternal FISH testing was normal.    
CLINICAL REPORTS 
Patient 1, the proband in Family A (Figure 1), is an African American male and was 
found to have the 7q11.23 duplication at age 4 on a SNP microarray performed due to a history 
of hypotonia, developmental delay, dysmorphic features, dysphagia and lung disease.  The 
patient had right orchidopexy and inguinal hernia repair at age 5 and at age 6, was noted to have 
mild intellectual disability, mixed receptive and expressive language disorder, and difficulty with 
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attention regulation (Table I).  He originally presented with aortic dilation in infancy identified 
on echocardiographic evaluation of a murmur.  His cardiac evaluations have continued to 
demonstrate dilation of the aortic root, sinotubular junction, and ascending aorta, as well as a 
patent ductus arteriosus.  Beta-blocker therapy was initiated at age 5.    
Patient 2, the proband’s maternal half-sister, was subsequently found to have the 7q11.23 
duplication through FISH at age 10.  She has a history of learning difficulty and severely 
deficient receptive language skills, as well as dysmorphic features.  She is noted to make fair 
grades in a traditional education setting with supports from an individualized education plan.  
Her cardiac evaluation revealed dilation of the ascending aorta and a small patent foramen ovale.  
An unaffected maternal half-sibling had a normal echocardiogram with the exception of a small 
patent foramen ovale.   The affected mother has not had a formal evaluation and thus was not 
included in this report.  She is reported to have an unspecified mental health diagnosis.   
The proband in Family B (Figure 1), Patient 3, is a biracial Caucasian and African 
American female and was found to have the 7q11.23 duplication at age 3 on a SNP microarray 
performed due to a history of developmental delay and dysmorphic features.    In addition to the 
7q duplication, the proband was also found to have a 1.68Mb deletion of 15q13.2-15q13.3, 
which was paternally inherited but absent in her other siblings.  This deletion overlaps with the 
recurrent 15q13.3 microdeletion region, which has been proposed to be associated with 
developmental delay, dysmorphic features, epilepsy, and behavioral abnormalities, but also 
identified in apparently normal individuals [Masurel-Paulet et al., 2010]. The proband’s initial 
cardiac evaluation performed at age 3 due to a family history of cardiomyopathy identified aortic 
root and sinotubular junction dimensions at the upper limits of normal and minor left ventricular 
apical trabeculations.  Subsequent imaging revealed mild dilation of the aortic root, sinotubular 
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junction, and ascending aorta at age 4 which normalized by age 7.  At age 7 she was noted to 
have learning difficulty, communication disorder, attention deficit and gross and fine motor 
delay.  She was receiving special education services.   
The proband’s brother (Patient 4) and maternal half-sister (Patient 5), both also biracial, 
were subsequently found to have the duplication through FISH analysis.  Their mother (Patient 
6) has not had genetic testing and thus the possibility of germline mosaicism cannot be excluded.  
At age 5, Patient 4 has a history of mild speech delay with speech therapy received at age 4 but 
ceasing in kindergarten at age 5.  His initial cardiac evaluation was performed at age 2 due to the 
family history of cardiomyopathy, and he was found to have aortic root dimensions at the upper 
limits of normal.  Subsequent evaluations at ages 5 and 6 revealed aortic findings in the 
borderline to mildly dilated range.    He is also noted to have prominent left ventricular free wall 
trabeculations.   
Patient 5, also a biracial female, was diagnosed with dilated cardiomyopathy (DCM) in 
infancy and required initial hospitalization for approximately a month after her diagnosis.  She 
was later also noted to have left ventricular noncompaction cardiomyopathy (LVNC).  After her 
hospitalization she reportedly had failure to thrive with feeding difficulty and NG tube 
requirement for six months.  At age 14 she was noted to have normal growth and development 
but did have dysmorphic features.  She was found to have the 7q11.23 duplication at age 15.   
Patient 5 had been followed by Cardiology with many echocardiograms performed since infancy 
due to her diagnosis of cardiomyopathy. She had negative genetic testing for DCM through a 
gene panel including 19 genes.  The patient was admitted to a cardiac intensive care unit at age 
15 with a suspected bacterial infection and had severe cardiac decompensation.  She died during 
that admission subsequent to heart failure associated with her diagnosis of cardiomyopathy.    
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Review of aortic findings from her cardiac imaging showed mild aortic root dilation between the 
ages of 6 and 8 before normalization of aortic dimensions.   
Patient 6 in Family B, a Caucasian female, reported a history of learning disability and 
auditory discrimination problems.  She was noted to have mild dysmorphic features which were 
not further specified.  An echocardiogram performed at age 34 revealed mild dilation of the 
ascending aorta.   
Patient 7 presented with intractable seizures around the age of 5 years. Brain MRI 
revealed cortical thickening extending from the medial left parietal lobe to the anterior left 
temporal lobe, consistent with cortical dysplasia. Her intellectual functioning was assessed using 
the WISC – IV at the age of 11 years and was found to have a Full Scale IQ of 42. 
Echocardiogram showed a mildly dilated ascending aorta. On physical exam, her growth 
parameters were appropriate for age.  No facial dysmorphic features were noted. Her 
neurological exam was normal. The patient had one healthy sibling, with no family history of 
aortopathy.  
Patient 8 was ascertained at 3 months of age with seizures. EEG showed focal epileptic 
discharges in the right fronto-parietal region, which normalized by 6 years of age. Brain MRI 
indicated dysmorphic prominent supratentorial ventricular system. Echocardiogram at 2 years of 
age showed mildly dilated ascending aorta, with normal aortic root and sinotubular junction. At 5 
years, the echocardiogram continued to show a mildly dilated ascending aorta.The aortic root 
and sinotubular junction measured within normal limits for body surface area. His overall 
development was delayed, with severe language deficits. On physical exam, his stature was 
105.9 cm (Z=-2.11), and his weight was 14.6kg (Z=-3.09). No dysmorphic features were noted 
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on exam. Both parents were reportedly healthy. The duplication was found to be de novo in this 
patient.  
Patient 9 is a Caucasian female who presented at age 37 months for evaluation of 
developmental delays, dysmorphic features, and a seizure disorder. Details of her delays are 
unknown. Early milestone history from parents seemed normal but she received play, physical 
and speech therapies from age 8 months to almost 3 years. Records describe symptoms of 
anxiety, sad expression without reason to be sad, and withdrawn behaviors. An evaluation at 2yr 
4mo showed normal speech development. The seizure history included a febrile seizure at age 14 
months and subsequent “staring spells” of unclear significance. On physical exam, she is 
overweight and has macrocephaly (+3SD> the mean), a prominent forehead, the appearance of 
closely spaced eyes and short palpebral fissures (interpupillary and palpebral fissure 
measurements were 3rd-25th centile for chronologic age and << 3rd for her head circumference 
age of 12 years), a narrow nasal tip with prominent grooves between tip and alae, and a shy 
affect with poor eye contact and no communication. Her echocardiogram showed a normal aortic 
valve annulus size and function and a moderately dilated ascending aorta.  The family history is 
very complex with neurodevelopmental problems on both sides.   
Genetic testing for these patients was performed on a clinical basis.  No patients were 
found to have features of Marfan syndrome, Loeys Dietz syndrome, or another connective tissue 
disorder which prompted investigation of other genetic causes of aortopathy.   
Cardiac Phenotype 
All individuals with the duplication in this series demonstrated aortic dilation ranging 
from mild to moderate (Table I).  Dilation of the ascending aorta (AAo) (Figure 2, panel C) was 
identified in 8/9 patients; dilation of the aortic root (AoR) and/or sinotubular junction (STJ) were 
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also seen, but less frequently (4/9 and 2/9, respectively). Insufficient information is available on 
the lifetime risk for progressive aortic disease in these individuals, but dilation appears to be 
stable, at least over the first decade of life, based on a limited number of observations (Figure 1, 
panels A and B).  Longitudinal data is available for a subset of patients.  At this time, only single 
measurements are available for Patients 6, 7, and 9.  One individual was found to have a silent 
patent ductus arteriosus, which has been previously reported in association with the 7q11.23 
microduplication syndrome.  Both affected individuals in Family A are on a beta-blocker for 
medical management of their aortopathy.   
The duplication phenotype in Family B is complicated by the coexisting diagnosis of 
dilated cardiomyopathy (DCM) and left ventricular non-compaction (LVNC) in Patient 5 and 
prominent left ventricular trabeculations in two other relatives carrying the duplication (Patients 
3 and 4).  Patient 5 had dilation of the AoR present from approximately 6 to 8 years of age, with 
a normal AoR dimension documented at age 8.  This patient died at age 14 due to heart failure 
secondary to cardiomyopathy.  In this family, Patient 3 also demonstrated normalization of aortic 
dimensions from age 4 to age 7, and Patient 4 demonstrated a similar pattern with only 
borderline dilation of the aortic root at 6 years of age.  Neither Patient 3 nor 4 have received 
medical therapy, but they continue to be followed with serial echocardiograms and clinical 
evaluations. 
In both Family A and B, a half-sibling of the proband without the duplication has had an 
echocardiogram demonstrating normal aortic dimensions, consistent with segregation of 
aortopathy with the duplication (Figure 1).  No additional affected relatives are available for 
evaluation in these families.   
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DISCUSSION 
Here we characterize the cardiac findings and extracardiac features in 9 patients with the 
7q11.23 microduplication syndrome.  Aortic dilation was identified in all individuals, with no 
individuals demonstrating marked progression of their aortopathy over baseline and two 
individuals demonstrating normalization of their aortic dimensions over time.  Consistent with 
previous reports, we identified one individual with a patent ductus arteriosus.  While congenital 
heart disease has been identified in patients previously, aortic dilation has not been described in 
those individuals.  However, the ages at which previously described patients had an 
echocardiogram which identified the heart defect, or if serial surveillance was performed, is 
unknown.  It is also unclear whether previously reported individuals who were not described as 
having congenital heart disease ever had cardiac imaging.  Therefore, we cannot comment on the 
presence or absence of aortopathy in these previously described patients.   
Extracardiac features previously reported as common to the duplication were observed in 
this series including language delay and dysmorphic features.  Only one individual in this series 
was not found to have a history of developmental delay, learning disability, need for 
developmental therapy, or behavioral concerns.  In light of identification of the 7q11.23 
microduplication in individuals with schizophrenia and other behavioral concerns, we note 
concern for a mental health disorder in an adult relative known to have the duplication, but not 
included in this series as she has not had a cardiac evaluation. 
Previous references have been made to the apparent opposite phenotypes caused by the 
7q11.23 deletion and duplication, including opposing dysmorphic features and the relative 
strength/weakness in expressive language [Dixit et al., 2013].  Additional reciprocal 
deletions/duplications display similar evidence including opposing effect on growth associated 
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with the 1q21.1 locus as well as the 5q35 locus containing NSD1 [Brunetti-Pierri et al., 2008; 
Rosenfeld et al., 2013].  Here we demonstrate an interesting example of contrasting phenotypes 
involving the 7q11.23 locus, with SVAS commonly observed in WBS and aortic dilation 
identified in these individuals with the 7q11.23 microduplication syndrome.  While the SVAS in 
WBS has been attributed to ELN deletion, we postulate that a gene dosage effect of ELN may be 
the underlying cause for the aortopathy in these patients with the microduplication.  However at 
this time, the exact cause of aortic dilation in these patients is not known.  While the frequency 
of the observed aortopathy in the individuals presented here appears unlikely to have occurred by 
chance, we cannot rule out the possibility of another gene within the region of duplication being 
responsible for the aortic findings.     
The findings in this series support a recommendation for cardiovascular surveillance in 
all individuals with the 7q11.23 microduplication.  This series indicates a high penetrance of 
aortopathy occurring in childhood. Aortopathy is typically a silent disease until late stage 
disease, at which time morbidity and mortality are high. Early identification of aortic dilation 
provides the opportunity for medical intervention, thus periodic surveillance is indicated. While 
aortic disease in this series appeared to be stable, and to date there have been no reports of aortic 
dissection or rupture, two of the patients are on beta blocker therapy since their ascending aortic 
dimension z-scores are well over +3.0.  The 2010 Guidelines for the Diagnosis and Management 
of Patients with Thoracic Aortic Disease includes syndrome specific recommendations and risk 
stratification [Hiratzka et al., 2010].  This highlights the need to understand the genetic etiology 
in patients with thoracic aortic aneurysm and to fully delineate the natural history of genetic 
syndromes in which aortopathy is a feature.  This series adds 7q11.23 microduplication 
syndrome to that list.  Longitudinal studies are needed to determine the lifetime risk of 
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progressive aortopathy and sudden cardiac death, so that evidence-based recommendations may 
be made regarding frequency of surveillance and the timing and impact of medical intervention.    
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A.   Family A   
 
 
 
 
 
 
B.  Family B  
 
 
 
 
 
 
Figure 1.  Pedigrees. A.  The proband and one maternal half-sister have both been confirmed to have the 
microduplication and aortopathy.  A half-sister without the duplication had an echocardiogram at age 7 documenting 
normal aortic dimensions.  The mother with the duplication has not had cardiac imaging.  B.  The proband and the 
affected parent and siblings have had cardiac imaging exhibiting aortopathy.  The sole unaffected sibling has had 
several echocardiograms (due to the family history of cardiomyopathy) with normal aortic dimensions, most 
recently at age 4.  No additional relatives from either family have had cardiac imaging.   
No aortopathy 
PFO 
No 
cardiac 
imaging 7q11.23 
Microduplication 
Aortopathy 
No aortopathy 
Minor LV 
trabeculations 
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Figure 2.  Dilation of the aorta in patients with 7q11.23 microduplication syndrome. A, Serial measurements of the 
aortic root in Patient 1, according to standard protocol . B, Serial measurements of the ascending aorta in Patient 2. 
C, Echocardiographic parasternal long axis image of Patient 2. Sites 1, 2 and 3 indicate location of the aortic valve 
annulus, aortic root and sinotubular junction, respectively. Site 4 is the ascending aorta, with the dashed line 
delineating the dimension of the ascending aorta. 
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Table I Cardiac and Extracardiac Phenotypic Features   
Patient 
ID 
 
Gender Age at 
echocardiogram 
Site of 
aortic 
dilation* 
z-score 
 
Other Cardiac 
Features 
Extracardiac Clinic 
History 
Dysmorphic Features 
Family A 
1 Male 6 months 
 
 
 
6 years  
6 months 
 
 
7 years 
6 months 
Root 
STJ 
AAo 
 
Root 
STJ 
AAo 
 
Root 
STJ 
AAo 
2.2 
2.3 
5.2 
 
2.8 
2.1 
3.5 
 
2.1 
2.6 
5.1 
Patent Ductus 
Arteriosus 
Mild intellectual 
disability, mixed 
receptive and 
expressive language 
disorder, hypotonia, 
cryptorchidism 
Broad forehead, broad and 
flat nasal bridge, mild 
epicanthus inversus, small 
low-set ears with mildly 
thickened helices 
2 Female 11 years  
1 month 
 
11 years  
7 months 
 
12 years  
1 month 
AAo 
 
 
AAo 
 
 
AAo 
3.6 
 
 
3.4 
 
 
3.2 
Small Patent 
foramen ovale 
Learning difficulty, 
communication 
disorder, receptive 
language severely 
deficient 
Small mouth, depressed 
nasal tip 
Family B 
3 Female 4 years  
4 months 
 
 
6 years 
 
7 years 
Root 
STJ 
AAo 
 
Root 
 
Normal 
2.3 
2.3 
2.9 
 
2.1 
 
- 
Minor left 
ventricular 
apical 
trabeculations 
15q13.2q13.3 deletion, 
developmental delay, 
mixed receptive and 
expressive language 
disorder 
Short palpebral fissures, 
macrocephaly 
4 Male 2 years  
8 months 
 
5 years 
Root 
 
 
Root 
2.0 
 
 
2.5 
Prominent left 
ventricular free 
wall 
trabeculations 
Speech delay Midface hypoplasia, mild 
hyperteolorism, straight 
eyebrows 
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6 years 
AAo 
 
Root 
2.3 
 
2.0 
5 Female 6 years  
9 months 
 
7 years  
10 months 
 
8 years  
10 months 
Root 
 
 
Root 
 
 
Normal 
3.1 
 
 
2.7 
 
 
- 
Dilated 
cardiomyopathy, 
Left ventricular 
noncompaction 
- Short upslanting palpebral 
fissures, bilateral 
epicanthal folds, bulbous 
nose, mildly posteriorly 
rotated ears 
6 Female 34 years  
1 month 
AAo 2.8 - Learning disability Mild dysmorphic features, 
not further specified 
Family C 
7 N/A 11 years 
 
 
AAo 
 
3.0 - Cognitive delay, 
epilepsy, cortical 
dysplasia 
No facial dysmorphism 
noted  
Family D 
8 N/A 2 years 
6 months 
 
3 years  
7 months 
 
5 years 
4months 
AAo 
 
 
AAo 
 
 
AAo 
2.4 
 
 
3.1 
 
 
2.7 
-  Autism, short stature Dysmorphic features, not 
further specified; 
microcephaly 
Family E 
9 Female 3 years 5 
months 
AAo 3.5 - Early milestones 
reportedly normal but 
received play, physical 
and speech therapy; 
behavior withdrawn 
and anxious; febrile 
seizure; current staring 
spells of unclear cause  
Prominent forehead, 
narrow nasal tip, 
prominent grooves 
between tip and alae,  
BMI >97th centile, 
macrocephaly (maternal 
trait) 
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*Normal measurements are not listed unless a measurement was shown to normalize over time, in which case age at normalization is listed; Root – 
aortic root, STJ – sinotubular junction, AAo – ascending aorta 
(-) indicates normal 
